Skip to main content
CND In the News

Syn-One Test® Provides Much-Needed Answers for Georgia Man

By February 13, 2023June 6th, 2024No Comments

Syn-One Test®
Provides Much-Needed Answers for Georgia Man

Georgia Public Broadcasting featured a story this week about how the Syn-One Test helped Dr. Daniel Cobb, owner of The Neuro Center in Gainesville, Georgia, provide a diagnosis to Chris Griffin, a patient who was experiencing troubling and unexplained symptoms.

Dr. Cobb notes that before the Syn-One Test, a neurologist might have to follow a patient’s case for years or experiment with a medication before they could provide a patient with answers. In these difficult-to-diagnose cases, the minimally invasive Syn-One Test can provide visual proof of a misfolded form of the alpha-synuclein protein, which helps clinicians diagnose conditions like Parkinson’s disease and dementia with Lewy bodies.

Griffin expressed relief at receiving his diagnosis. “…now (that) I could name my demon, I could fight my demon.”

Read the story

CND Life Sciences

CND Life Sciences is the creator of the Syn-One Test™, the world’s first commercially available test to visualize abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test is an objective, evidence-based diagnostic tool to aid in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, or REM sleep behavior disorder.